Corporate Banner
Satellite Banner
Technology Networks Header
Friday, November 28, 2014
 
Register | Sign in
Home Page > Videos > Automated Sequencing Analysis Tool for Infectious Disease Diagnostics
  Videos

Return

Automated Sequencing Analysis Tool for Infectious Disease Diagnostics
Zova Systems

The Zova Systems team has worked on automated sample prep, eukaryotic and bacterial DNA separation kits and data analyses pipelines to facilitate the use of Next-Gen Sequencing (NGS; e.g. 454, HiSeq, IonTorrent, PacBio) for comprehensive microbial species identification. For fast, robust data analysis we have developed ZovaSeq, an analysis pipeline and relational database that can be operational wholly contained on a laptop or a large multi-processor computer network. Initially developed for biothreat detection, we have expanded the database with all known NCBI microbial species. With a simple right click on an NGS data file, ZovaSeq automatically mines the gigabases of data in a logical, tiered approach and outputs reports containing successively increasing analysis resolution: identification of microbial species, relevant markers or SNPs, closest microbial strain as well as relevant plots and coverage tables. ZovaSeq identification can take place at several taxonomical levels so novel pathogenic species (e.g. Coronavirus SARS) can be identified. We are currently in collaboration with groups working with Cystic Fibrosis patients and hospital air monitoring. A workflow from sample to sequence using several novel technologies will be presented.

Request more information
Company product page



For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here

Scientific News
Gene Therapy Provides Safe, Long-Term Relief for Patients with Severe Hemophilia B
Gene therapy pioneered by St. Jude Children’s Research Hospital, University College London and the Royal Free Hospital provides men with hemophilia B reliable relief from the bleeding disorder.
Protein Predicts Response To New Immunotherapy Drug
Trial shows that response to treatment may be predicted by the presence of an immune-suppressing protein in non-cancerous immune cells.
NIAID/GSK Experimental Ebola Vaccine Appears Safe, Prompts Immune Response
Results from NIH Phase 1 clinical trial support accelerated development of candidate vaccine.
Researchers Develop Efficient Method to Produce Nanoporous Metals
New technique to manufacture nanoporous metals is cheap and can be done over many scales.
Turkeys may be Lifesavers
Antibiotic to target staph infections, strep, comes from good bacteria in turkeys.
A Hybrid Vehicle That Delivers DNA
University at Buffalo researchers are developing new technology to improve DNA vaccines. The new transport system for DNA vaccines could help treat HIV, malaria, HPV and other major illnesses.
Big Data Set To Make A Big Difference In Childhood Cancer Treatment
UTS researchers are working with the Kids Research Institute to visualise large quantities of patient data to better diagnose and treat childhood cancer patients.
Two Studies Identify A Detectable, Pre-Cancerous State In The Blood
Findings pave way for new lines of cancer research focused on detection and prevention.
A Link between DNA Transcription and Disease-Causing Expansions Which Lead to Hereditary Disorders
A Tufts University study explores the relationship between transcription and the expansions of DNA repeats.
Did You Hear The One About The Two Businessmen On A Plane?
EquipNet’s vision ‘to revolutionize the way companies manage their surplus assets’ was first conceived at 30,000 feet somewhere between Chicago and Boston in 1999. Here we learn more about the company's first 15 years.
Scroll Up
Scroll Down
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv